Trademark: 79309367
Status Date
Tuesday, July 12, 2022
Registration Number
6784066
Registration Date
Tuesday, July 12, 2022
Filing Date
Thursday, February 4, 2021
Published for Opposition
Tuesday, April 26, 2022
5 Pharmaceutical and veterinary preparations for the treatment of cancer and for cancer therapies used in the treatment of cancer; stem cells for medical purposes; stem cells for medical and veterinary use; DNA and RNA for medical and veterinary purposes, namely, gene-based RNA molecular network biomarker reagents for medical diagnosis purposes, Medical therapeutic preparations in the nature of biologically active antisense DNA or RNA compounds, Biological products for medical use in recombinant DNA technology in the nature of DNA products allowing recombinant production of polypeptides and monoclonal antibodies; surgical implants grown from stem cells comprising living tissues; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; biological preparations for the treatment of cancer for medical and veterinary purposes; diagnostic kit consisting of stem cells, monoclonal antibodies and proteins for use in disease testing for medical and veterinary purposes; Reagents for medical use, namely, reagents for medical diagnosis and analysis; diagnostic preparations for medical and veterinary use
1 Biological preparations for use in industry and science; stem cells for research or scientific purposes; antibodies for research and industrial purposes, namely, Biochemicals in the nature of monoclonal antibodies for in vitro scientific or research use, Laboratory chemicals in the nature of an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use, Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; DNA and RNA for scientific and industrial purposes, namely, Test particles for biodetection systems, biological analogues and microscopic carrier beads with chemically attached DNA fragments for use in testing the operation of equipment used for analyzing air for the presence of harmful biological substances, Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields, Reagent kit comprising enzyme and chemicals for in vitro transcription of RNA and modified RNA, Gene-based RNA molecular network biomarker reagents for research purposes; proteins for use in science being protein in raw material form for scientific research; chemical test kits, consisting of stem cells, antibodies and proteins, for scientific and industrial purposes for laboratory or research use; reagents for scientific purposes; diagnostic reagents for scientific purposes, not for medical or veterinary purposes; analytical preparations being Chemical buffer and standard solutions used in analytical chemistry, Reagents used for analytical moisture determinations, Reagents for use in scientific apparatus for chemical or biological analysis, Laboratory chemicals in the nature of an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use, Chemical substances for analyses in laboratories, other than for medical or veterinary purposes for scientific purposes related to cancer treatment and therapies
42 Scientific research; laboratory testing services, namely, scientific research, diagnosis, testing and analysis in the fields of medicine, chemistry, stem cells, RNA, DNA, antibodies and proteins; basic and clinical research in the field of respiratory science and medicine, in particular in relation to the development of medicines; research and development services in the field of diagnostic preparations; quality control for others
The wording "TARGINTA" has no meaning in a foreign language.
Oct 19, 2022
Final Disposition Notice Sent To Ib
Oct 19, 2022
Final Disposition Processed
Oct 12, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jul 12, 2022
Notice Of Registration Confirmation Emailed
Jul 12, 2022
Registered-Principal Register
May 3, 2022
Notification Processed By Ib
Apr 26, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 26, 2022
Published For Opposition
Apr 13, 2022
Notification Of Possible Opposition Sent To Ib
Apr 13, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 6, 2022
Notification Of Notice Of Publication E-Mailed
Mar 24, 2022
Approved For Pub - Principal Register
Mar 24, 2022
Examiner's Amendment Entered
Mar 24, 2022
Notification Of Examiners Amendment E-Mailed
Mar 24, 2022
Examiners Amendment E-Mailed
Mar 24, 2022
Examiners Amendment -Written
Mar 16, 2022
Teas/Email Correspondence Entered
Mar 15, 2022
Correspondence Received In Law Office
Mar 15, 2022
Teas Response To Office Action Received
Mar 9, 2022
Assigned To Examiner
Oct 25, 2021
Refusal Processed By Ib
Sep 27, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Sep 27, 2021
Refusal Processed By Mpu
Sep 10, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Sep 9, 2021
Non-Final Action Written
Aug 27, 2021
Assigned To Examiner
Apr 27, 2021
Application Filing Receipt Mailed
Apr 23, 2021
New Application Office Supplied Data Entered In Tram
Apr 22, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
